Skip to main content
. 2012 Nov 28;97(2):112–121. doi: 10.1016/j.antiviral.2012.11.006

Table 2.

Inhibition of HCoV-NL63 and MHV replication in vitro.

Polymer HCoV-NL63 MHV
IC LLC-MK2 (CPEa) IC50 LLC-MK2 (qRT-PCRb) IC50 LR7 (qRT-PCRb)
HTCC 10 μg/ml 2.75 ± 1.18 μg/ml [13.41 nM] 6.82 ± 1.16 μg/ml [33.27 nM]
HM-HTCC 50 μg/ml 68.52 ± 18.71 μg/ml [308.65 nM] 72.33 ± 18.24 μg/ml [325.81 nM]
a

Lowest compound concentration for which no CPE was noted.

b

50% inhibitory concentration as assessed by real-time RT-PCR analysis.